22:55 Corium up 51% on go-private deal - Corium International, Inc. (NASDAQ:CORI)
Thinly traded Corium International (CORI +50.7%) is up on a whopping 83x surge in volume following its announcement that Gurnet Point Capital will acquire its outstanding shares at $12.50 each.
The transaction also includes a Contingent Value Right (CVR) of $0.50 per share payable upon FDA approval for lead candidate Corplex Donepezil for Alzheimer's disease prior to March 31, 2020.
The deal should close by year-end. Afterward, Corium will offer to repurchase all of its $120M in convertible debt.
Subscribe for full text news in your inbox
Copyright © 2013-2018 www.meiguwiki.com All Rights Reserved